The European Asthma Research and Innovation Partnership (EARIP) aims to reduce asthma deaths in Europe by 25% within ten years and by 50% within 20 years. The partnership, made up of 12 European-based organisations, also aims to halve hospital admission rates, speed up the discovery of new treatments and improve self-management. The EARIP project will do this through identifying key gaps in asthma knowledge; it will then address these using a pioneering and integrated approach to research, development and innovation across Europe. Through rapid dissemination of project results, EARIP will ensure that outcomes from knowledge-based asthma research will quickly result in an improved quality of life for people with asthma.
Recent Posts
- The impact of dosage timing for inhaled corticosteroids in asthma: a randomised three-way crossover trial
- Surfactant proteins levels in asthmatic patients and their correlation with severity of asthma: a systematic review
- BTS/NICE/SIGN guideline for asthma 2024: Diagnosis, monitoring and chronic asthma management. How does this compare to GINA 2024?
- Association of eosinophil-to-monocyte ratio with asthma exacerbations in adults: a cross-sectional analysis of NHANES data
- Connecting the Dots: How MicroRNAs Link Asthma and Atherosclerosis